<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s4{background-color:#ffffff;text-align:left;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s0{background-color:#ffffff;text-align:left;font-weight:bold;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Roboto',Arial;font-size:10pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Roboto',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="28731386C0" style="width:764px;" class="column-headers-background">A</th><th id="28731386C1" style="width:764px;" class="column-headers-background">B</th></tr></thead><tbody><tr style="height: 20px"><th id="28731386R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0" dir="ltr">Antepartum Haemorrhage based on GTG 63</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s1" dir="ltr"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s1">Summary<br>Definitions: spotting is staining / streaking / wiping; minor is &lt; 50 ml and not ongoing; major is 50-1000 ml without shock; massive is &gt;1000mls and/or signs of shock<br>Kleihauer if &gt; 20 weeks<br>Discharge at initial assessment if spotting only, no longer bleeding, and no concern of praevia if assessment reassuring, all other cases home after admission, senior review and bleeding settled<br>Tocolysis can be considered by a senior obstetrician, shouldn&#39;t be used with significant concerns of maternal-fetal wellbeing<br>Following single or recurrent episodes of APH from a cervical ectropion, subsequent antenatal care need not be altered.<br>Serial scans for any cause of APH other than ectropion<br>If maternal or fetal compromise from APH suspected, consider general anaesthetic<br>Following APH, advise active 3rd stage to reduce blood loss, particularly syntometrine if no hypertension and APH due to abruption or praevia.<br>If massive haemorrhage and/or abruption, consider DIC, send clotting and FBC and seek haem support, consider 4 units FFP and 10 units cryo<br></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s2" dir="ltr">Definitions</td><td class="s1" dir="ltr">Summary</td></tr><tr style="height: 20px"><th id="28731386R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s1" dir="ltr">Spotting – staining, streaking or blood spotting noted on underwear or sanitary protection </td><td class="s1" dir="ltr">Definitions: spotting is staining / streaking / wiping; minor is &lt; 50 ml and not ongoing; major is 50-1000 ml without shock; massive is &gt;1000mls and/or signs of shock</td></tr><tr style="height: 20px"><th id="28731386R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td class="s3" dir="ltr">Minor haemorrhage – blood loss less than 50 ml that has settled </td><td></td></tr><tr style="height: 20px"><th id="28731386R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s3" dir="ltr">Major haemorrhage – blood loss of 50–1000 ml, with no signs of clinical shock </td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s3" dir="ltr">Massive haemorrhage – blood loss greater than 1000 ml and/or signs of clinical shock.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s2" dir="ltr">Prevention</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s1" dir="ltr">Cannot be predicted</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s1" dir="ltr">Women should be advised, encouraged and helped to change modifiable risk factors (such as smoking and drug misuse)</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s2" dir="ltr">Management</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s1" dir="ltr">It is recommended that women be advised to report all vaginal bleeding to their antenatal care provider. </td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s3" dir="ltr">Women with APH presenting to a midwifery-led maternity unit, a general practitioner or to an accident and emergency department should be assessed, stabilised if necessary and transferred to a hospital maternity unit with facilities for resuscitation (such as anaesthetic support and blood transfusion resources) and performing emergency operative delivery. </td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s3" dir="ltr">A multidisciplinary team including midwifery and obstetric staff, with immediate access to laboratory, theatre, neonatal and anaesthetic services, should provide clinical assessment.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s1" dir="ltr">Triage of APH includes: includes history taking to assess coexisting symptoms such as pain, an assessment of the extent of vaginal bleeding, the cardiovascular condition of the mother, and an assessment of fetal wellbeing.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s1" dir="ltr">The Kleihauer test should be performed in rhesus D (RhD)-negative women to quantify fetomaternal haemorrhage (FMH) in order to gauge the dose of anti-D immunoglobulin (anti-D Ig) required</td><td class="s1" dir="ltr">Kleihauer if &gt; 20 weeks</td></tr><tr style="height: 20px"><th id="28731386R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s1" dir="ltr">In the context of suspected vasa praevia various tests exist that can differentiate between fetal and maternal blood, but are often not applicable.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td class="s4" dir="ltr">Admission</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td class="s1" dir="ltr">Women presenting with spotting who are no longer bleeding and where placenta praevia has been excluded can go home after a reassuring initial clinical assessment. </td><td class="s1" dir="ltr">Discharge at initial assessment if spotting only, no longer bleeding, and no concern of praevia if assessment reassuring, all other cases home after admission, senior review and bleeding settled</td></tr><tr style="height: 20px"><th id="28731386R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s3" dir="ltr">All women with APH heavier than spotting and women with ongoing bleeding should remain in hospital at least until the bleeding has stopped.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td class="s4" dir="ltr">Steroids</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td class="s1" dir="ltr">Clinicians should offer a single course of antenatal corticosteroids to women between 24+0 and 34+6 weeks of gestation at risk of preterm birth.uld still be considered.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R30" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">31</div></th><td class="s3" dir="ltr">In women presenting with spotting, where the most likely cause is lower genital tract bleeding, where imminent delivery is unlikely, corticosteroids are unlikely to be of benefit, but co</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R31" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">32</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R32" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">33</div></th><td class="s4" dir="ltr">Tocolysis</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R33" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">34</div></th><td class="s1" dir="ltr">Tocolysis should not be used to delay delivery in a woman presenting with a major APH, or who is haemodynamically unstable, or if there is evidence of fetal compromise. </td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R34" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">35</div></th><td class="s3" dir="ltr">A senior obstetrician should make any decision regarding the initiation of tocolysis in the event of an APH.</td><td class="s1" dir="ltr">Tocolysis can be considered by a senior obstetrician, shouldn&#39;t be used with significant concerns of maternal-fetal wellbeing</td></tr><tr style="height: 20px"><th id="28731386R35" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">36</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R36" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">37</div></th><td class="s4" dir="ltr">Antenatal Clinic</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R37" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">38</div></th><td class="s1" dir="ltr">Following single or recurrent episodes of APH from a cervical ectropion, subsequent antenatal care need not be altered.</td><td class="s1" dir="ltr">Following single or recurrent episodes of APH from a cervical ectropion, subsequent antenatal care need not be altered.</td></tr><tr style="height: 20px"><th id="28731386R38" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">39</div></th><td class="s3" dir="ltr">Following APH from placental abruption or unexplained APH, the pregnancy should be reclassified as ‘high risk’ and antenatal care should be consultant-led.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R39" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">40</div></th><td class="s3" dir="ltr">Serial ultrasound for fetal growth should be performed</td><td class="s1" dir="ltr">Serial scans for any cause of APH other than ectropion</td></tr><tr style="height: 20px"><th id="28731386R40" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">41</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R41" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">42</div></th><td class="s4" dir="ltr">Delivery</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R42" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">43</div></th><td class="s1" dir="ltr">If maternal or fetal compromise from APH suspected, consider general anaesthetic</td><td class="s1">If maternal or fetal compromise from APH suspected, consider general anaesthetic</td></tr><tr style="height: 20px"><th id="28731386R43" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">44</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R44" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">45</div></th><td class="s4" dir="ltr">3rd stage</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R45" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">46</div></th><td class="s1" dir="ltr">Following APH, advise active 3rd stage to reduce blood loss, particularly syntometrine if no hypertension and APH due to abruption or praevia.</td><td class="s1">Following APH, advise active 3rd stage to reduce blood loss, particularly syntometrine if no hypertension and APH due to abruption or praevia.</td></tr><tr style="height: 20px"><th id="28731386R46" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">47</div></th><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R47" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">48</div></th><td class="s4" dir="ltr">APH and resultant coagulopathy</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R48" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">49</div></th><td class="s1" dir="ltr">In women who have experienced a massive blood loss or a major abruption, the development of a disseminated intravascular coagulation (DIC) should be considered. </td><td class="s1" dir="ltr">If massive haemorrhage and/or abruption, consider DIC, send clotting and FBC and seek haem support, consider 4 units FFP and 10 units cryo</td></tr><tr style="height: 20px"><th id="28731386R49" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">50</div></th><td class="s5" dir="ltr">Clotting studies and a platelet count should be urgently requested and advice from a haematologist sought.</td><td class="s1"></td></tr><tr style="height: 20px"><th id="28731386R50" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">51</div></th><td class="s5" dir="ltr">Up to 4 units of FFP and 10 units of cryoprecipitate may be given whilst awaiting the results of the coagulation studies.</td><td class="s1"></td></tr></tbody></table></div>